Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
4m
BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
Study exceeded target enrollment, with an expected topline data readout from the interim analysis expected in 2025 - ...
Medscape
4h
Pfizer's Withdrawal of SCD Drug Raises Questions
Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...
Swissinfo
6h
Medicines regulators weigh hope and hype with new Alzheimer’s drugs
Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
Illegal cloning sentencing
NYC tunnel shutdown
Harris' Las Vegas rally
Grammy-winning singer dies
Trump's Erie rally
Blocks songs from artists
Crew-9 astronauts at ISS
Oil prices climb
Three PFLP leaders killed
Actor John Ashton dies
Firefighters injured in crash
Defensive Player of the Year
$567M Taiwan defense aid
Line Fire prompts evacuation
Newsom vetoes AI safety bill
US wins Presidents Cup
37 militants killed in Syria
‘Wild Robot' tops box office
'Days of Our Lives' star dies
Hospitalized for burns
NC small plane crash
Temporary outage fixed
Ga. chemical plant fire
Condemns Israeli strikes
Ukrainian drones shot down
'SNL' launches 50th season
Steward CEO to step down
Faces fine to end Brazil ban
Chief adviser subpoenaed
Related topics
Oxbryta
sickle cell disease
Feedback